Skip to content

Near point-of-care viral load testing enables quick clinical action for people with high viral load

Laboratory technician at the Lighthouse Trust, Lilongwe, Malawi

Ten-year Italian study shows that people with HIV remain undetectable for 97% of the time

Domizia Salusest | www.domiziasalusest.com

Near point-of-care viral load tests slash waiting times in seven African countries

Haba Pokpa, MSF Lab Technician in the MSF supported laboratory in Matam health centre, Conakry, Guinea captures results from GeneXpert tests. Image by Albert Masais/MSF.

CD4 count testing has reduced with only a modest increase in viral load monitoring in southern Africa

Image: Leonie Broekstra/Shutterstock.com

Elite controllers may self-vaccinate against active HIV infection, gene study suggests

Image: Kateryna Kon/Shutterstock.com

Low level detectable viral load while taking HIV treatment is associated with poorer medical outcomes

Image: phloxii/Shutterstock.com

Delaying treatment changes when first-line ART fails costs lives, says South African study

A variety of antiretroviral drugs used to treat HIV infection. Credit: NIAID. Creative Commons licence.

Black MSM are 60% less likely to have suppressed HIV than white men in Atlanta

Image: Jarun Ontakrai/Shutterstock.com

Many gay men living with HIV have a misconception about their current viral load, US survey finds

Jarun Ontakrai/Shutterstock.com